Home › Funds › Krensavage Asset Management, LLC › ABT

Krensavage Asset Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Krensavage Asset Management, LLC reported holding 200,000 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$18.1M, representing 6.89% of its reported portfolio and ranking #6 among its reported holdings. Krensavage Asset Management, LLC has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)200.00K sh
Reported value held$18.15M
Portfolio Weight6.89%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Krensavage Asset Management, LLC's ABT position evolved

Krensavage Asset Management, LLC first disclosed a stake in ABT in Q1 2026 at 5,000 shares (US$513K). The position peaked in Q2 2026 at 200,000 shares, worth US$18.1M. Across 2 filings, Krensavage Asset Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 200,000 shares valued at US$18.1M — an increase of 195,000 shares quarter over quarter.. Notable position changes include a 3900% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 5.00K $513.00K New
Q2 2026 200.00K $18.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Krensavage Asset Management, LLC held ABT?

Krensavage Asset Management, LLC has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Krensavage Asset Management, LLC's current position in ABT?

As of Q2 2026, Krensavage Asset Management, LLC holds 200.00K shares of ABT (ABBOTT LABORATORIES), valued at $18.15M, representing 6.89% of its reported portfolio and ranking #6.

Has Krensavage Asset Management, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC increased its position in ABT. The position peaked in Q2 2026 at 200.00K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.